NEW YORK--(BUSINESS WIRE)--
The shareholders of Medgaz, S.A., CEPSA and SONATRACH have exercised their pre-emptive acquisition rights, within the statutory timeframe, over Endesa Generación, S.A.’s 12% equity interest in the share capital of Medgaz. An agreement to sell to Fluxys SA/NV of Belgium was reached in last December. The transaction price, including the transfer price of the loan claim held by Endesa Generación against Medgaz, is Euro 87.5 million and is subject to the customary price adjustments.
The transaction is expected to close during the first half of 2013, once all the consents required to substitute the seller on the guarantees granted in respect of the Medgaz project financing have been obtained.
Madrid, 11 February 2013